Wu Xi Advanced Therapies
Biotechnology, 4751 League Is BLVD, Philadelphia, Pennsylvania, 19112, United States, 501-1000 Employees
Phone Number: 21********
Who is WUXI ADVANCED THERAPIES
WuXi Advanced Therapies - Accelerating Progress and Time to Market Integrated Manufacturing and Testing Service Platform Solutions From Gene of Interest to Global Commercial Launch The ad...
Read More
-
Headquarters: 4751 League Is BLVD, Philadelphia, Pennsylvania, 19112, United States
-
Date Founded: 2004
-
Employees: 501-1000
-
Revenue: $250 Million to $500 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 621111 |
Show More
Does something look wrong? Fix it. | View contact records from WUXI ADVANCED THERAPIES
WuXi Advanced Therapies Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding WuXi Advanced Therapies
Answer: WuXi Advanced Therapies's headquarters are located at 4751 League Is BLVD, Philadelphia, Pennsylvania, 19112, United States
Answer: WuXi Advanced Therapies's phone number is 21********
Answer: WuXi Advanced Therapies's official website is https://advancedtherapies.com
Answer: WuXi Advanced Therapies's revenue is $250 Million to $500 Million
Answer: WuXi Advanced Therapies's SIC: 2836
Answer: WuXi Advanced Therapies's NAICS: 621111
Answer: WuXi Advanced Therapies has 501-1000 employees
Answer: WuXi Advanced Therapies is in Biotechnology
Answer: WuXi Advanced Therapies contact info: Phone number: 21******** Website: https://advancedtherapies.com
Answer: WuXi Advanced Therapies - Accelerating Progress and Time to Market Integrated Manufacturing and Testing Service Platform Solutions From Gene of Interest to Global Commercial Launch The advanced therapies business unit of WuXi AppTec is a leading cell and gene therapy Contract Testing, Development and Manufacturing Organization (CTDMO) that is reducing the complexities of manufacturing by providing integrated platforms that enable cell and gene therapies to be developed, manufactured, and released faster and with greater predictability. Our Story By leveraging platforms and integrated testing, the Advanced Therapies business unit of WuXi AppTec is a streamlined Contract Testing, Development and Manufacturing Organization (CTDMO), pioneering the expedited development and commercialization of cell, gene, protein and viral-based therapies. This approach enables new biopharmaceuticals to be developed, manufactured and released faster and with greater predictability, thereby reducing the complexities of high-touch, multi-vendor production models. Our solutions help clients overcome challenges to commercialization, including process development, manufacturing capacity, analytical development, and raw materials management. Multiple, scale-able, enabling platforms integrate manufacturing, process development and testing capabilities to provide greater predictability and speed to clinic. Well positioned for growth, our investments in personnel and manufacturing continue to expand clinical and commercial capacities. Since 2004, WuXi AppTec has supported Advanced Therapy programs with an extensive infrastructure of state-of-the-art, GMP-compliant facilities, providing centers of excellence for manufacturing and testing.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month